相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic variants and mutations of PPM1D control the response to DNA damage
Crissy Dudgeon et al.
CELL CYCLE (2013)
A review on CXCR4/CXCL12 axis in oncology: No place to hide
Urszula M. Domanska et al.
EUROPEAN JOURNAL OF CANCER (2013)
Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint
Petra Kleiblova et al.
JOURNAL OF CELL BIOLOGY (2013)
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer
Elise Ruark et al.
NATURE (2013)
WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function
S. Pandolfi et al.
ONCOGENE (2013)
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor et al.
ACTA NEUROPATHOLOGICA (2012)
Medulloblastoma: a potpourri of distinct entities
Stefan Pfister
ACTA NEUROPATHOLOGICA (2012)
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Marcel Kool et al.
ACTA NEUROPATHOLOGICA (2012)
CXCR4 Activation Defines a New Subgroup of Sonic Hedgehog-Driven Medulloblastoma
Rajarshi Sengupta et al.
CANCER RESEARCH (2012)
Functional Genomics Identifies Drivers of Medulloblastoma Dissemination
Michael Mumert et al.
CANCER RESEARCH (2012)
p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease
Marco Gessi et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Trevor J. Pugh et al.
NATURE (2012)
Clonal selection drives genetic divergence of metastatic medulloblastoma
Xiaochong Wu et al.
NATURE (2012)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott et al.
NATURE (2012)
HDM2 promotes WIP1-mediated medulloblastoma growth
Meghan C. Buss et al.
NEURO-ONCOLOGY (2012)
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
David W. Ellison et al.
ACTA NEUROPATHOLOGICA (2011)
G Protein-Coupled Receptor Kinase 5 Phosphorylation of Hip Regulates Internalization of the Chemokine Receptor CXCR4
Breann L. Barker et al.
BIOCHEMISTRY (2011)
Adult Medulloblastoma Comprises Three Major Molecular Variants
Marc Remke et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
FSTL5 Is a Marker of Poor Prognosis in Non-WNT/Non-SHH Medulloblastoma
Marc Remke et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
Yoon-Jae Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables
David W. Ellison et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Role of LIM and SH3 Protein 1 (LASP1) in the Metastatic Dissemination of Medulloblastoma
Christopher Traenka et al.
CANCER RESEARCH (2010)
Ablation of Key Oncogenic Pathways by RITA-Reactivated p53 Is Required for Efficient Apoptosis
Vera V. Grinkevich et al.
CANCER CELL (2009)
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91
Katja von Hoff et al.
EUROPEAN JOURNAL OF CANCER (2009)
Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN Loci
Stefan Pfister et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Robert L. Yauch et al.
SCIENCE (2009)
Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
Sanjeev Shangary et al.
Annual Review of Pharmacology and Toxicology (2008)
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
Marcel Kool et al.
PLOS ONE (2008)
Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D
Robert C. Castellino et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
The Wip1 phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop
Xiongbin Lu et al.
CANCER CELL (2007)
Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival
Xiu-Wu Bian et al.
NEUROSURGERY (2007)
Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestine
Oleg N. Demidov et al.
CELL STEM CELL (2007)
Overexpressed TP73 induces apoptosis in medulloblastoma
Robert C. Castellino et al.
BMC CANCER (2007)
The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis
O. N. Demidov et al.
ONCOGENE (2007)
G-protein-coupled receptors and cancer
Robert T. Dorsam et al.
NATURE REVIEWS CANCER (2007)
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis
Steven C. Clifford et al.
CELL CYCLE (2006)
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
Amar Gajjar et al.
LANCET ONCOLOGY (2006)
Wip1 phosphatase modulates ATM-dependent signaling pathways
Sathyavageeswaran Shreeram et al.
MOLECULAR CELL (2006)
Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1
Akinori Yoda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice
Bonnie Nannenga et al.
MOLECULAR CARCINOGENESIS (2006)
Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase
H. Fujimoto et al.
CELL DEATH AND DIFFERENTIATION (2006)
Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas
Chlara Calatozzolo et al.
CANCER BIOLOGY & THERAPY (2006)
Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies
BM Woerner et al.
CANCER RESEARCH (2005)
Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma
F Mendrzyk et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints
XB Lu et al.
GENES & DEVELOPMENT (2005)
Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood
DJ Mabbott et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients
JM Lamont et al.
CLINICAL CANCER RESEARCH (2004)
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors
N Issaeva et al.
NATURE MEDICINE (2004)
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
JB Rubin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice
G Rao et al.
NEOPLASIA (2003)
Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor:: A SEER update
DE McNeil et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2002)
Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity
DV Bulavin et al.
NATURE GENETICS (2002)
Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23
J Li et al.
NATURE GENETICS (2002)
p53-inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation
M Takekawa et al.
EMBO JOURNAL (2000)
分享论文
